Project Grant HT94252310423
Award Date
8/15/23
Completion Date
8/14/27
Dollars Obligated
$1.7M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
This federal Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support the "DEVELOPMENT OF INNOVATIVE THERAPEUTICS AGAINST PRESSURE ULCER-ASSOCIATED BACTERIA" at New York University School of Medicine. The $1,695,467.00 award, active from August 15, 2023 to August 14, 2027, will fund research to develop innovative treatments against bacteria associated with pressure ulcers. As a private...
New York University School of Medicine was awarded a $762,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund a research project titled "BEYOND VEXAS AND UBA1: IDENTIFICATION OF NOVEL DRIVERS OF MDS AUTOIMMUNE SYNDROMES" from June 15, 2023 through June 14, 2026. The grant supports research to identify novel drivers of myelodysplastic syndromes, blood disorders that can progress...
This $749,343 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports research by New York University School of Medicine on a "PEPTIDE TREATMENT FOR CARTILAGE INJURIES AND POST-TRAUMATIC OSTEOARTHRITIS". The award period runs from August 1, 2025 to July 31, 2027 and aims to develop innovative approaches to prevent, diagnose, and treat medical conditions relevant to military...
The Department of the Army Medical Command awarded New York University School of Medicine a $1,186,500 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through August 2024 to understand the transition from nevi to melanoma occurring within the skin epidermis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military...
The Defense Health Agency awarded Syracuse University a $1,099,513 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to develop antimicrobial shape memory polymer foams for rapid hemorrhage control and infection prevention in traumatic wounds. The grant period runs from August 15, 2023 to August 14, 2026. The research aims to transform health care for Service Members and the American public through innovative and impactful biomedical research focused on...
The New York University will receive $936,199 under a Project Grant award from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care. Under this three-year award beginning September 2022, New York University researchers will investigate receptors in endosomes that mediate chronic pain associated with trauma,...
The federal Project Grant award of $2,013,978.00 to New York University School of Medicine was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research focused on "Targeting RAGE After Particulate Matter Exposure: Metabolic Dysregulation and Disease Mitigation." The research aims to investigate innovative approaches to disease prevention, diagnosis, treatment, and management, with a...
This federal Project Grant award of $2,278,276.00 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) will fund research by New York University (NYU) to optimize psychological health and prevent clinical problems. The three-year project will test the effectiveness of an evidence-based toolkit for integrated operational support. NYU has extensive experience conducting federal grant-funded research across a range of domains,...
This $254,153 federal Project Grant award, funded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at New York University (NYU) School of Medicine. The award period is from March 1, 2025 to February 28, 2027. The grant will fund research to investigate the relationship between microplastics and prostate cancer. As a leading academic medical institution, NYU School of Medicine will...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $320,000.00 to New York University School of Medicine to conduct research evaluating insurance-driven disparities in access to high-efficacy therapies for multiple sclerosis. The award period runs from October 1, 2024 to September 30, 2026. As a leading academic medical center, NYU School of Medicine will leverage its expertise in...